Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercanto HoldingsTGSHF 33 Debt-to-Equity is 0.14 as of Apr. 2026, which is at its 10-year median of 0.14. GuruFocus rates TGSHF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 815 Drug Manufacturers companies, Mercanto Holdings ranks better than 66.13% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Mercanto Holdings's Debt-to-Equity or its related term are showing as below:
TGSHF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.14 Max: 0.71
Current: 0.14
During the past 5 years, the highest Debt-to-Equity Ratio of Mercanto Holdings was 0.71. The lowest was 0.01. And the median was 0.14.
TGSHF's Debt-to-Equity is ranked better than 66.13% of 815
companies
in the Drug Manufacturers industry
Industry Median: 0.28
vs TGSHF: 0.14
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Mercanto Holdings Debt-to-Equity Related Terms
Mercanto Holdings Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Mercanto Holdings's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mercanto Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercanto Holdings Debt-to-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mercanto Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Mercanto Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercanto Holdings (TGSHF) has a Debt-to-Equity of 0.14 as of Apr. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Mercanto Holdings and its competitors. This is near median its historical median of 0.14. Over the past decade, Mercanto Holdings' Debt-to-Equity has ranged from 0.01 to 0.71. According to the industry distribution chart, Mercanto Holdings ranks #276 out of 815 companies in the Drug Manufacturers industry, placing it in the top 33.9%.
Is Mercanto Holdings' Debt-to-Equity too high?
Mercanto Holdings' current Debt-to-Equity of 0.14 is near median its 10-year median of 0.14. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.71. The Drug Manufacturers industry median Debt-to-Equity is 0.28. Mercanto Holdings' value of 0.14 is 50% below this industry median. Based on the distribution chart, Mercanto Holdings ranks #276 out of 815 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Mercanto Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Mercanto Holdings' Debt-to-Equity compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mercanto Holdings ranks #276 out of 815 companies for Debt-to-Equity. This puts Mercanto Holdings in the upper half of its industry. The industry median Debt-to-Equity is 0.28. Mercanto Holdings' value of 0.14 is 50% below this benchmark. Historically, Mercanto Holdings' own Debt-to-Equity has ranged from 0.01 to 0.71 over the past decade. While the company's 10-year median is 0.14 vs. the industry median of 0.28, Mercanto Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Drug Manufacturers company?
The median Debt-to-Equity among Drug Manufacturers companies is 0.28, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercanto Holdings's current Debt-to-Equity of 0.14 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Mercanto Holdings and its competitors. For the Drug Manufacturers industry, the median Debt-to-Equity is 0.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercanto Holdings's current Debt-to-Equity is 0.14, which is near median its own 10-year median of 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercanto Holdings stock overvalued right now?
Mercanto Holdings (TGSHF) has a current Debt-to-Equity of 0.14. The current Debt-to-Equity is 0.14, which is near median its 10-year median of 0.14 and 50% below the Drug Manufacturers industry median of 0.28. Mercanto Holdings' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Mercanto Holdings (TGSHF), the current Debt-to-Equity is 0.14 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.
33GF Score
Get the complete analysis for TGSHF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGSHF has been successfully added to your 
